13F
← All fund report cards

BAILLIE GIFFORD & CO

13F equity value
$97.9B
Positions
271
Top 10 concentration
42.5%
Quarters / total new picks
32 / 421
13F equity value over time
$0M$103B$205B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +4.1% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 53.1% of quarters (excess t = -0.82, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-2.1%
t-stat
-0.82
Quarterly win rate
53%
Annualized excess
+3.7%
$1 → follow vs universe
$2.71 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.10820180630: follow 0.86020180930: follow 0.91520181231: follow 0.98320190331: follow 1.33820190630: follow 1.06920190930: follow 1.09120191231: follow 1.07120200331: follow 1.27120200630: follow 1.44020200930: follow 2.05820201231: follow 1.91020210331: follow 2.05720210630: follow 2.41120210930: follow 2.30120211231: follow 1.97120220331: follow 2.31220220630: follow 2.05620220930: follow 2.01520221231: follow 2.05620230331: follow 2.31720230630: follow 2.25620230930: follow 2.46820231231: follow 2.43920240331: follow 2.29120240630: follow 2.37420240930: follow 2.60820241231: follow 2.34220250331: follow 2.57820250630: follow 2.41520250930: follow 2.63420251231: follow 2.715 0.79 1.86 2.93 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 271 · 2026 Q1

Ticker Value Weight QoQ
NVDA $7.1B
7.3%
TRIM
AMZN $5.9B
6.0%
TRIM
MELI $5.6B
5.7%
TRIM
SPOT $4.0B
4.1%
HOLD
NU $3.5B
3.6%
TRIM
SHOP $3.4B
3.5%
TRIM
NET $3.3B
3.4%
TRIM
SE $3.3B
3.4%
ADD
PDD $2.9B
3.0%
TRIM
APP $2.7B
2.7%
ADD
META $2.3B
2.4%
TRIM
CPNG $2.3B
2.3%
TRIM
NFLX $2.1B
2.1%
TRIM
IOT $1.8B
1.9%
ADD
MSFT $1.4B
1.5%
TRIM
RACE $1.3B
1.3%
HOLD
RBLX $1.2B
1.2%
HOLD
ISRG $1.2B
1.2%
HOLD
RKLB $1.2B
1.2%
ADD
DASH $1.1B
1.1%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.